Bryan M. Lee, Chief Financial Officer of Five9, Inc. (NASDAQ:FIVN), filed a Form 4 on September 9, 2026, disclosing four sales of common stock executed on September 4 and September 8, 2026.
Alexandre Clerc, Senior Vice President of Customers at Frontier Group Holdings, Inc., filed a statement of changes in beneficial ownership on September 9, 2026, disclosing a sale of common stock that occurred on September 4, 2026.
Steve Schuller, Senior Vice President of Human Resources at Frontier Group Holdings, Inc., filed a Form 4 on September 9, 2026, disclosing the sale of 7,500 shares of common stock on September 4, 2026.
Jason Drew Smith, General Counsel of UroGen Pharma Ltd. (NASDAQ:URGN), filed a Form 4 on September 9, 2026, disclosing the vesting of restricted stock units and a subsequent sale of ordinary shares on September 7 and 8, 2026.
JFrog Ltd Chief Technology Officer Yoav Landman filed a Form 4 with the SEC on September 9, 2026, disclosing the sale of ordinary shares on September 4, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
A statement of changes in beneficial ownership for Alkami Technology, Inc. (NASDAQ:ALKT) was filed on September 9, 2026, disclosing a share disposition by Chief Executive Officer Alex Shootman on September 8, 2026.
Mark Schoenberg, Chief Medical Officer of UroGen Pharma Ltd. (NASDAQ:URGN), filed a Form 4 on September 9, 2026, reporting the vesting of restricted stock units and a subsequent sale of ordinary shares on September 7 and 8, 2026.
Director Mikael Dolsten filed a statement of changes in beneficial ownership with the SEC on September 9, 2026, disclosing a sale of Agilent Technologies, Inc. common stock on September 4, 2026.
David G. Cutler, Chief Technology Officer of National Vision Holdings, Inc. (NASDAQ:EYE), filed a Form 4 on September 9, 2026, disclosing transactions in common stock and restricted stock units dated September 8, 2026.
A Form 4 filed on September 9, 2026 discloses that Richard N. Barton, a director of Netflix Inc (NASDAQ:NFLX), exercised stock options and sold shares of common stock on September 8, 2026 pursuant to a Rule 10b5-1 trading plan.